Poor benefit/risk balance of intravenous immunoglobulins in DRESS

Archives of Dermatology

Volumn 148, Issue 4, 2012, Pages 543-544

  Joly, Pascal ^a   Janela, Baptiste ^a   Tetart, Florence ^a   Rogez, Sylvie ^b   Picard, Damien ^a   D'Incan, Michel ^c   Descamps, Vincent ^d   Collet, Evelyne ^e   Roujeau, Jean Claude ^f   Musette, Philippe ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d BICHAT HOSPITAL   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRESS SYNDROME; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERTENSION; HYPOTENSION; LUNG EMBOLISM; MALAISE; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; RISK BENEFIT ANALYSIS; SERODIAGNOSIS; TREATMENT RESPONSE; VIRUS REACTIVATION;

ADRENAL CORTEX HORMONES; ADULT; AGED; CYTOMEGALOVIRUS; DISEASE PROGRESSION; DRUG ERUPTIONS; EOSINOPHILIA; FEMALE; FEVER; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; RISK ASSESSMENT; TUMOR NECROSIS FACTORS; VIRUS ACTIVATION;

EID: 84859958072     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.148.4.dlt120002-c     Document Type: Article

References (5)

1. Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;157(5):934-940. (Pubitemid 47583515)
2. Picard D, Janela B, Descamps V, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med. 2010;2(46):46ra62.
3. Fields KS, Petersen MJ, Chiao E, Tristani-Firouzi P. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J Drugs Dermatol. 2005;4(4):510-513.
4. Kano Y, Inaoka M, Sakuma K, Shiohara T. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology. 2005;209(2):165-167. (Pubitemid 40568645)
5. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609-611.